Predictive factors for acute esophageal toxicity in thoracic radiotherapy

Tohoku Journal of Experimental Medicine

Volumn 208, Issue 4, 2006, Pages 299-306

  Takeda, Ken ^a   Nemoto, Kenji ^b   Saito, Haruo ^a   Ogawa, Yoshihiro ^b   Takai, Yoshihiro ^b   Yamada, Shogo ^b  

^a SENDAI CITY MEDICAL CENTER   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute esophageal toxicity; Predictions; Radiotherapy; Thoracic neoplasms

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; VINCRISTINE SULFATE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSIMETRY; ESOPHAGUS INJURY; FEMALE; FOLLOW UP; HUMAN; JAPAN; LIPOSARCOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; SEMINOMA; STATISTICAL SIGNIFICANCE; THORAX CANCER; THORAX SURGERY; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COMBINED MODALITY THERAPY; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; THORACIC NEOPLASMS;

EID: 33645233303     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.208.299     Document Type: Article

References (19)

1. Ahn, S.J., Kahn, D., Zhou, S., Yu, X., Hollis, D., Shafman, T.D. & Marks, L.B. (2005) Dosimetric and clinical predictors for radiation-induced esophageal injury. Int. J. Radiat. Oncol. Biol. Phys., 61, 335-347.
2. Bradley, J., Deasy, J.O., Bentzen, S. & El-Naqa, I. (2004) Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 58, 1106-1113.
3. Bruner, D.W., Movsas, B., Konski, A., Roach, M., Bondy, M., Scarintino, C., Scott, C. & Curran, W. (2004) Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual. Life Res., 13, 1025-1041.
4. Byhardt, R.W., Scott, C., Sause, W.T., Emami, B., Komaki, R., Fisher, B., Lee, J.S. & Lawton, C. (1998) Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys., 42, 469-478.
5. Chen, Y.Y., Huang, C.H., Tang, Y. & Eng, H.L. (2004) Concurrent chemoradiotherapy for unresectable thymic carcinoma. Chang. Gung. Med. J., 27, 515-522.
6. Choy, H., LaPorte, K., Knill-Selby, E., Mohr, P. & Shyr, Y. (1999) Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin. Radiat. Oncol., 9, 90-96.
7. Clifford, Chao, K.S., Perez, C.A. & Brady, L.W. (2002) Radiation Oncology, Management Decisions, 2nd ed., Williams & Wilkins, Philadelphia, pp. 2-3.
8. Cox, J.D., Stez, J. & Pajak, T.F. (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EOR TIC). Int. J. Radiat. Oncol. Biol. Phys., 31, 1341-1346.
9. Hirota, S., Tsujino, K., Endo, M., Kotani, Y., Satouchi, M., Kado, T., Hishikawa, Y., Obayashi, K., Takada, Y., Kono, M. & Abe, M. (2001a) Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 51, 291-295.
10. Hirota, S., Tsujino, K., Hishikawa, Y., Watanabe, H., Kono, K., Soejima, T., Obayashi, K., Takada, Y., Kono, M. & Abe, M. (2001b) Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother. Oncol., 58, 273-278.
11. International Commission on Radiation Units and Measurements (1993) ICRU Report No. 50. Prescribing, Recording, and Reporting Photon Beam Therapy. Bethesda, MD: International Commission on Radiation Units and Measurements, Washington, DC.
12. Kim, T.H., Cho, K.H., Pyo, H.R., Lee, J.S., Han, J.Y., Zo, J.I., Lee, J.M., Hong, E.K., Choi, I.J., Park, S.Y., Shin, K.H., Kim, D.Y. & Kim, J.Y. (2005) Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 62, 995-1002.
13. Masaoka, A., Monden, Y., Nakahara, K. & Tanioka, T. (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer, 48, 2485-2492.
14. Patel, A.B., Edelman, M.J., Kwok, Y., Krasna, M.J. & Suntharalingam, M. (2004) Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int. J. Radiat. Oncol. Biol. Phys., 60, 1106-1112.
15. Perez, R.A. & Early, D.S. (2002) Endoscopy in patients receiving radiation therapy to the thorax. Dig. Dis. Sci., 47, 79-83.
16. Sailer, S.L. (2000) Three- dimensional conformal radiation therapy. In: Clinical radiation oncology, edited by L.L. Gunderson & J.E. Tepper, Philadelphia, Churchill Livingstone, pp. 243-245.
17. Singh, A.K., Lockett, M.A. & Bradley, J.D. (2003) Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 55, 337-341.
18. Takeda, K., Nemoto, K., Saito H., Ogawa, Y., Takai, Y. & Yamada, S. (2005) Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 62, 626-629.
19. Werner-Wasik, M., Pequignot, E., Leeper, D., Hauck, W. & Curran, W. (2000) Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int. J. Radiat. Oncol. Biol. Phys., 48, 689-696.